Don’t take it from me, it’s all available 3 weeks ago in the investor conference
- phase 2 trials are next year and are in America and for both stroke and TBI together - Phase 2 will look to take the grant from the US department of defence after Walter reed - Phase 1 will do both Stroke and TBI on Australia - drug will be fast tracked because of its indication and no drug put there does what it does
Hawk70 you’re trolling now and making things up again. Phase 1 is in human testing testing for safety and dosage and also if the drug is doing what it’s supposed to be doing on the brain.
This isn’t a 10 million market cap drug and on the upside it’s where AGN is which is a 100 million dollar drug. Answer my question why is AGN a 100 million market cap? Also why is phase 1 completed in Australia and phase 2 that starts next year in America? I thought you need FDA phase 1 and they can’t start phase 2 for years and years hahaha Your lying again Hawk70
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)